The Prostate Cancer Clinical Trials Consortium (PCCTC)

📍 New York, United States🗓 Founded 2014👥 29 employees💰 Last funded Mar 2019
The PCCTC’s distinguished investigators work together on a single mission: to design, implement and complete hypothesis-driven early phase trials in prostate cancer, translating scientific discoveries to improved standards of care. We offer services to carry out this mission ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2014
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in The Prostate Cancer Clinical Trials Consortium (PCCTC)?
The Prostate Cancer Clinical Trials Consortium (PCCTC) has 1 investor on record on gritt.io, 1 mid-stage.
When did The Prostate Cancer Clinical Trials Consortium (PCCTC) last raise funding?
The most recent investment in The Prostate Cancer Clinical Trials Consortium (PCCTC) recorded on gritt.io was in March 2019.
When was The Prostate Cancer Clinical Trials Consortium (PCCTC) founded?
The Prostate Cancer Clinical Trials Consortium (PCCTC) was founded in 2014.
What industry is The Prostate Cancer Clinical Trials Consortium (PCCTC) in?
The Prostate Cancer Clinical Trials Consortium (PCCTC) operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is The Prostate Cancer Clinical Trials Consortium (PCCTC) based?
The Prostate Cancer Clinical Trials Consortium (PCCTC) is headquartered in New York, United States.